TNF Archives - Medical Conferences

PsoBest registry: Biologics dominate treatment for moderate-to-severe psoriasis

Presented By

Prof. Matthias Augustin, University Medical Center Hamburg-Eppendorf, Germany

Trial

PsoBest registry

Conference

EADV 2024

Type

Peer-reviewed article

6 November 2024 12:23

Advanced therapies show promising results in PsA real-world study

Presented By

Prof. Dennis McGonagle, University of Leeds, UK

Trial

PRO-SPIRIT

Conference

EULAR 2024

Type

Peer-reviewed article

29 July 2024 14:38

How close are we to personalised medicine in psoriatic arthritis?

Presented By

Prof. Ennio Lubrano, University of Molise, Ital

Conference

IFPA 2024

Type

News article

17 July 2024 14:38

Depression complicates the management of psoriatic disease

Presented By

Dr Wiebke Sondermann, University Hospital Essen, Germany

Conference

IFPA 2024

Type

News article

17 July 2024 14:20

Improving outcomes in pregnancy and psoriatic disease

Presented By

Dr Oseme Etomi, Guy's and St Thomas' Hospital, UK

Conference

IFPA 2024

Type

News article

17 July 2024 13:44

Biologics in psoriatic arthritis: where we are and where we are headed

Presented By

Dr Vinod Chandran

Conference

IFPA 2024

Type

News article

17 July 2024 11:55

Biologicals and JAK inhibitors hold promise in microscopic colitis

Presented By

Dr Bram Verstockt, University Hospitals Leuven, Belgium

Conference

ECCO 2024

Type

Peer-reviewed article

18 April 2024 13:35

LUCENT trials: Mirikizumab works in UC, regardless of targeted therapy history

Presented By

Prof. Silvio Danese, Vita-Salute San Raffaele University, Italy

Trial

Phase 3, LUCENT-2

Conference

UEGW 2023

Type

Peer-reviewed article

7 December 2023 15:23

IL-23 blockers may lower the risk of developing inflammatory and psoriatic arthritis

Presented By

Prof. Bruce Strober, Yale University School of Medicine, USA

Conference

EADV 2023

Type

Peer-reviewed article

28 November 2023 12:01

Cardiovascular safety of JAK inhibitors: reassuring results from a real-world study

Presented By

Mr Romain Aymon, Geneva University Hospital, Switzerland

Trial

ORAL Surveillance

Conference

EULAR 2023

Type

Peer-reviewed article

31 July 2023 00:00

Early, post-operative complications in CD reduced by pre-operative enteral nutrition, irrespective of biologic exposure

Presented By

Prof. Mathurin Fumery, Amiens University Hospital, France

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:55

Anti-TNF withdrawal may be a safe option in stable IBD

Presented By

Prof. María Chaparro Sánchez , Hospital Universitario de La Princesa, Spain

Trial

Phase 4, EXIT

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:12

Intensified drug therapy leads to better stricture morphology in CD

Presented By

Dr Julien Schulberg , St Vincent’s Hospital Melbourne, Australia

Trial

STRIDENT

Conference

ECCO 2023

Type

Peer-reviewed article

4 May 2023 16:03

High retention rates after switching between infliximab biosimilars

Presented By

Dr Hafsah Nabi, Rigshospitalet, Denmar

Conference

ACR 2022

Type

News article

1 December 2022 14:21

New analysis assesses the safety of tofacitinib regarding extended MACE

Presented By

Prof. Maya Buch, University of Manchester, United Kingdom

Trial

ORAL Surveillance

Conference

ACR 2022

Type

News article

1 December 2022 14:18

Ankylosing spondylitis: Combining biologics with NSAID does not imply reduced radiographic progression

Presented By

Dr Fabian Proft, Charité University Hospital, Germany

Trial

Phase 4, CONSUL

Conference

ACR 2022

Type

News article

1 December 2022 14:08

High rate of non- or partial responders jeopardises therapeutic success in HS

Presented By

Dr Hayley Wallinger, Adelphi Real World, UK

Conference

EADV 2022

Type

Peer-reviewed article

5 November 2022 11:15

Intestinal alterations in patients with Parkinson’s disease

Presented By

Dr Gabriele Bellini, University of Pisa, Italy

Conference

EAN 2022

Type

Peer-reviewed article

22 August 2022 16:12

Treat-to-target dose reduction effective in spondyloarthritis

Presented By

Dr Celia Michielsens , Sint Maartenskliniek, the Netherlands

Conference

EULAR 2022

Type

Peer-reviewed article

21 July 2022 17:21

New insights into psoriasis comorbidity

Presented By

Prof. Joel Gelfand, University of Pennsylvania, USA

Conference

AAD 2022

Type

Peer-reviewed article

17 May 2022 12:12

Comparable safety profiles of biological therapies in elderly patients with IBD

Presented By

Dr Gustavo Drügg Hahn, McGill University Health Center, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 17:22

Stopping infliximab but not antimetabolites leads to more relapses in Crohn’s disease

Presented By

Prof. Edouard Louis, University Hospital Liège, Belgium

Trial

Phase 4, SPARE

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:55

Anti-TNFs versus vedolizumab and ustekinumab in Crohn’s disease

Presented By

Dr Neeraj Narula, McMaster University, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:46

Upadacitinib appears to be an efficacious therapy for moderately-to-severely ulcerative colitis

Presented By

Prof. Remo Panaccione , University of Calgary, Canada

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:44

Subcutaneous infliximab versus subcutaneous vedolizumab in IBD

Presented By

Prof. Laurent Peyrin-Biroulet, Nancy University Hospital, France

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:41

Vedolizumab outperforms anti-TNF in biologic-naïve ulcerative colitis

Presented By

Dr Bernd Bokemeyer, University Hospital Schleswig-Holstein, Germany

Trial

VEDO-IBD

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:37

Guselkumab plus golimumab promising combination for ulcerative colitis

Presented By

Prof. Bruce Sands, Mount Sinai School of Medicine, NY, USA

Trial

Phase 2, VEGA

Conference

ECCO 2022

Type

Peer-reviewed article

12 April 2022 16:10

TNF inhibitor for immune-mediated inflammatory disease doubles the risk of paradoxical psoriasis

Presented By

Dr Nikolai Loft, Copenhagen University Hospital, Denmark

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 15:08

The Yin and Yang of opposing vectors: an explanation for side effects of biologics

Presented By

Prof. Curdin Conrad, Lausanne University Hospital, Switzerland

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 11:07

Explaining arthropathy development through IL-4 and IL-13 blockade

Presented By

Dr Charlie Bridgewood, University of Leeds, UK

Conference

PFGC 2021

Type

Peer-reviewed article

3 February 2022 10:51

TNF blockers likely beneficial for psoriatic patients with COVID-19

Presented By

Prof. Catherine Smith, King’s College London, UK

Trial

PsoProtect

Conference

PFG 2021

Type

Peer-reviewed article

2 February 2022 15:42

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By

Dr Ali Al-Janabi, University of Manchester, UK

Conference

PFGC 2021

Type

Peer-reviewed article

2 February 2022 15:22

Why antipsychotics cause weight gain

Presented By

Prof. Louise Gallagher, University of Dublin, Ireland

Conference

ECNP 2021

Type

Peer-reviewed article

26 November 2021 11:18

Existing and upcoming small molecules in psoriasis

Presented By

Dr Enikö Sonkoly , Karolinska University Hospital, Sweden

Trial

POETYK PSO; PSOARING

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:19

Treating psoriasis during pregnancies

Presented By

Prof. Mahira Hamdy El Sayed, Ain Shams University, Egypt

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:18

Grand debate: Is psoriasis a systemic or skin-only disease?

Presented By

Prof. Brian Kirby & Prof. Stefano Piaserico

Conference

EADV 2021

Type

Peer-reviewed article

18 November 2021 13:14

Serologic response to COVID-19 mRNA vaccine reduced in IBD patients on anti-TNFα

Presented By

Ms Hadar Edelman-Klapper, Rabin Medical Center, Israel

Conference

UEGW 2021

Type

News article

27 October 2021 09:50

JAK inhibitors and bDMARDs not associated with increased risk of serious infections in RA

Presented By

Dr Anja Strangfeld, German Rheumatism Research Centre Berlin, Germany

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:53

Rituximab or JAK inhibitors increase the risk of severe COVID-19

Presented By

Dr Jeffrey Sparks, Brigham and Women’s Hospital, MA, USA

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 23:36

Guselkumab efficacious in PsA patients with inadequate response to TNF inhibition

Presented By

Dr Laura Coates , University of Oxford, UK

Trial

Phase 3, COSMOS

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 22:06

ABBV-3373: A potential new therapeutic agent for RA

Presented By

Dr Frank Buttgereit, Charité University Medicine, Germany

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 19:05

JAK inhibitors and bDMARDs show comparable effectiveness

Presented By

Mr Andrei Barbulescu, Karolinska Institutet, Sweden

Conference

EULAR 2021

Type

Peer-reviewed article

2 August 2021 10:23

Similar efficacy of ustekinumab and adalimumab for moderate-to-severe CD

Presented By

Dr Peter Irving, Guy’s and St. Thomas’ Hospital, UK

Trial

SEAVUE

Conference

ECCO 2021

Type

News article

2 July 2021 23:45

Surgical closure plus anti-TNF outperforms anti-TNF alone for perianal fistula

Presented By

Ms Elise Meima-van Praag , Amsterdam University Medical Centre, the Netherlands

Trial

PISA-II

Conference

ECCO 2021

Type

News article

2 July 2021 21:45

Obesity increases the risk of immunogenicity to adalimumab in IBD

Presented By

Dr Remi Mahmoud, University Medical Centre Utrecht, the Netherlands

Conference

ECCO 2021

Type

News article

2 July 2021 14:24

Psoriasis and hidradenitis suppurativa during COVID-19: keep calm and carry on

Presented By

Prof. April W. Armstrong, University of Southern California, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:32

Psoriasis management in times of COVID-19: the knowledge is growing steadily

Presented By

Prof. Joel Gelfand, University of Pennsylvania Perelman School of Medicine, PA, USA

Conference

AAD VMX 2021

Type

Peer-reviewed article

7 June 2021 13:31

COVID-19 in patients with rheumatic disease: most report mild disease

Presented By

Dr Akhil Sood, University of Texas Medical Branch, USA

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:57

Poor disease control: a risk factor for severe COVID-19

Presented By

Prof. Rebecca Grainger, University of Otago, New Zealand

Trial

COVID-19 Global Rheumatology Alliance Registry

Conference

ACR 2020

Type

Peer-reviewed article

18 January 2021 10:57

E-cigarettes: A source of chronic lung inflammation

Presented By

Prof. Shama Ahmad, University of Alabama at Birmingham, USA

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 19:08

COVID-19 and inflammatory rheumatic disease: some key issues

Presented By

Prof. G. Burmester, Charité University Hospital, Germany

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 15:06

Ixekizumab shows sustained improvements in pain and fatigue at 3 years

Presented By

Prof. Ana-Maria Orbai, Johns Hopkins University School of Medicine, USA

Trial

SPIRIT-P2

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 14:15

Worse response axSpA patients to second TNFi versus first TNFi

Presented By

Dr Santiago Rodrigues-Manica, Hospital Egas Moniz, Portugal

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:27

AxSpA real-life remission rates higher on biologics

Presented By

Dr Charlotte Baert, Saint Luc University Hospital, Belgium

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:24

Certolizumab pegol reduces acute anterior uveitis in axial spondyloarthritis

Presented By

Prof. Irene van der Horst-Bruinsma, Amsterdam University Medical Center, the Netherlands

Trial

C-VIEW

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:19

TNF-α inhibitors improve bone mineral density in AS patients

Presented By

Mark Siderius, University Medical Center Groningen; Medical Center Leeuwarden, the Netherlands

Conference

EULAR 2020

Type

Peer-reviewed article

14 August 2020 10:13

Psoriasis therapy for children and pregnancies

Presented By

Prof. Mark Lebwohl, Icahn School of Medicine at Mount Sinai, USA

Trial

CRIB, CADMUS, IXORA-PEDS

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 08:03

Can gene expression help to pick the right biologic to treat psoriasis in cancer patients?

Presented By

Dr Nikolai Klebanov , Brigham and Women’s Hospital, USA

Conference

AAD 2020

Type

Peer-reviewed article

6 August 2020 07:01

Early ileocaecal resection in CD patients failing conventional treatment

Presented By

Dr T. Stevens, Amsterdam UMC, the Netherlands

Trial

LIR!C

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 15:11

Infliximab discontinuation increases relapse risk

Presented By

Kobayashi T, Kitasato University, Japan

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 14:41

Pipeline of IBD drugs

Presented By

Prof. W. Sandborn, University of California San Diego, USA

Conference

ECCO 2020

Type

Peer-reviewed article

14 April 2020 13:55

Impact of biologicals on faecal microbiota

Presented By

C. Caenepeel, KU Leuven, Belgium

Conference

ECCO 2020

14 April 2020 10:20

Experimental model for limitations of haematopoietic stem cells propagation

Presented By

Dr Jennifer Myers SanMiguel, The Jackson Laboratory, USA

Conference

ASH 2019

Type

Peer-reviewed article

5 March 2020 14:47

Lowest risk of infection after therapy with an IL-12/IL-23 blocker

Presented By

Dr Yinzhu Jin, Brigham and Women´s Hospital and Harvard Medical School, Boston, USA

Trial

Cohort study

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:42

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By

Dr Evelyne Vinet, McGill University, Montreal, Canada

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 23:12

Tocilizumab outperforms rituximab in RA patients with low level of synovial B cell infiltration

Presented By

Prof. Costantino Pitzalis, Barts and The London School of Medicine and Dentistry, UK

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 20:10

TNFi for RA during pregnancy – to stop or not to stop?

Presented By

Dr Isabell Haase, Heinrich-Heine University Düsseldorf, Germany

Conference

ACR 2019

Type

Peer-reviewed article

4 February 2020 10:16

Biologics: increasingly used in paediatric dermatology

Presented By

Prof. Marieke Seyger, Radboud University Nijmegen, the Netherlands

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 15:16

ESPRIT registry: sharp decline in mortality in patients treated with a TNF blocker

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Trial

ESPRIT

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 19:23

Certolizumab pegol efficacious for head and neck psoriasis

Presented By

Prof. Peter van de Kerkhof, Radboud University, the Netherlands

Trial

Phase 3, CIMPASI-1 and CIMPASI-2

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 15:02

Inflammation may change the course of Parkinson’s disease

Presented By

Prof. Vidar Gundersen, University of Oslo, Norway

Conference

EAN 2019

Type

Peer-reviewed article

27 September 2019 23:47

Clinical effectiveness of fenebrutinib in RA patients with methotrexate or TNFi failure

Presented By

Dr Stanley Cohen, Metroplex Clinical Research Center, Dallas, USA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 21:38

Switching upadacitinib and adalimumab is beneficial in refractory RA

Trial

Phase 3, SELECT-COMPARE

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 17:54

Preliminary efficacy and safety data of RG6125 in RA patients with an inadequate response to TNF inhibitors

Presented By

Uwe Junker, Roche Innovation Center Basel, Switzerland

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 14:01

Efficacy and safety of ixekizumab versus adalimumab in patients with PsA

Presented By

Dr Roy Fleischmann, University of Texas Southwestern Medical Center, Dallas, USA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 11:20

Efficacy and safety of bimekizumab in patients with active PsA

Presented By

Dr Christopher Ritchlin, University of Rochester Medical Centre, USA

Trial

Phase 2, BE ACTIVE

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 11:10

Ixekizumab improves signs and symptoms in TNFi-naïve PsA patients

Presented By

Dr Amanda Gellett, Eli Lilly, USA

Trial

Phase 3, SPIRIT-P2

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:50

Etanercept and methotrexate as first-line treatment in PsA

Presented By

Prof. Philip Mease, University of Washington, USA

Trial

Phase 3, SEAM-PsA

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:40

Unacceptable pain is common in patients with psoriatic arthritis

Presented By

Dr Tor Olofsson, Lund University, Sweden

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:33

NSAIDs consumption is linked to patient-assessed disease activity and decreases with use of TNF inhibitors

Presented By

Dr Olafur Palsson, University Hospital Reykjavik, Iceland

Trial

ICEBIO database

Conference

EULAR 2019

Type

Peer-reviewed article

4 September 2019 10:11

Biologicals beyond TNF blockade

Presented By

Prof. Brian Kirby, St. Vincent’s University Hospital, Ireland

Conference

WCD 2019

Type

Peer-reviewed article

26 August 2019 11:11

Advances in target-oriented therapy: psoriatic arthritis

Presented By

Prof. Wolf-Henning Boehncke, University of Geneva, Switzerland

Trial

ECLIPSA, TICOPA

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 23:48

Results from the ECLIPSE trial: does blocking IL-23 have better long-term outcomes in psoriasis?

Presented By

Prof. Kristian Reich, Georg-August-University Göttingen, Germany

Trial

ECLIPSE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 18:23

Small molecules, apremilast, and TYK2

Presented By

Prof. Richard Langley, Dalhousie University, Canada

Trial

ESTEEM, PALACE, LIBERATE

Conference

SPIN 2019

Type

Peer-reviewed article

21 June 2019 09:45

HDAC6 inhibition by CKD-506

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 23:18

Molecular effects of ustekinumab

Trial

Phase 3, UNITI

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 19:47

Gene expression signature predicts non-response

Trial

ACT1, PURSUIT-SC, PROgECT, PURSUIT-J, UNITI

Conference

ECCO 2019

Type

Peer-reviewed article

9 May 2019 18:48

JAK inhibitors: a new therapeutic tool for dermatologists

Presented By

Prof. Brett King, Yale School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 20:08

Psoriasis and Biologics: The Beat Goes On

Presented By

Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA

Conference

AAD 2019

Type

Peer-reviewed article

19 April 2019 14:06

Synergistic effect NSAIDs plus TNFi in slowing radiographic progression in ankylosing spondylitis patients

Presented By

Dr Gensler, University of California San Francisco Medical Center, USA

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 22:48

No significant differences when tapering TNF blockers versus csDMARDs

Presented By

Dr Van Mulligen, Erasmus MC, the Netherlands

Conference

EULAR 2018

Type

Peer-reviewed article

24 August 2018 21:51

Central role of IL-23 in molecular resistance to anti-TNF therapy

Conference

ECCO 2018

Type

Peer-reviewed article

28 May 2018 21:06

Higher rates of remission and healing with vedolizumab vs TNF antagonist

Conference

ECCO 2018

Type

Peer-reviewed article

28 May 2018 17:57